Santen Phase III Study Meets Primary Endpoint for the Treatment of Non ... PharmiWeb.com (press release) Ltd. (Osaka Japan) today announced that SAKURA (Study Assessing double-masKed Uveitis tReAtment) Study 1 the first of two Global Phase III studies evaluating intravitreal injections of sirolimus in patients with non-infectious posterior segment uveitis ... Primary Endpoint Met in Eye Disorder Study |
